Biological specimens’ receipt, storage, management and distribution
Closed Pre-Solicitation Posted
- Solicitation number
- HHS-NIH-NIDA-PSOL-75N95022R00091
- Agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- Place of performance
- Bethesda, Maryland 20814, United States
Notice details come from SAM.gov. Updated .
Notice text
INTRODUCTION
PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION.
The National Institute on Drug Abuse (NIDA), Station Support Contracts and Simplified Acquisitions Branch (SS/SA) on behalf of the National Institute on Aging “intends to re-compete a requirement currently being performed by Precision For Medicine, Inc. under NIA Contract HHSN271201800020C.
EXTENT OF COMPETITION
- This acquisition isfull and open with no set-aside restrictions
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 541380 with a Size Standard of $16.5 Million.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2022-08, dated 10/28/2022.
This acquisition is conducted under the procedures as prescribed inFAR Subpart 15—Contracting by Negotiation at an amount exceeding the simplified acquisition threshold inclusive of options.
DESCRIPTION OF REQUIREMENT
Project Description
This requirement is for the receipt, storage, management, and distribution of biological specimens stored in the AgingResearchBiobank.
Purpose and Objectives
The purpose of this requirement is to give continuity to research and development services already in place for existing resources, improve these services, and expand the Aging Research Biobank collection by bringing additional new biospecimens from ongoing or new studies or from collections already stored in the Aging Research Biobank. This Biological Specimens Receipt, Storage, Management, and Distribution component of the Aging Research Biobank is aimed to accomplish the following in a highly efficient, rapid, secure, and cost-effective manner as summarized: A. Planning and logistics to ensure provision of a scientific, technical, and administrative infrastructure that supports efficient planning, initiation, implementation, and management of the Aging Research Biobank activities. B. Securing, receiving, cataloging, processing, storing, and disbursing human biological specimens from NIA-sponsored studies or studies approved to have their biospecimens and related phenotypic and clinical data and other resources included in the Aging Research Biobank. C. Providing adequate cold storage facilities and equipment (freezers are to be acquired with Federal funds under this requirement) that will help secure, catalogue, process, store, and disburse biospecimens following Biospecimen Repository Best Practices as defined by the International Society of Biological and Experimental Repositories-ISBER (http://www.isber.org) or by the National Cancer Institute (NCI) available at https://biospecimens.cancer.gov/bestpractices/. D. Providing a secure back-up system and a plan for disaster recovery. E. Developing, performing, and maintaining Quality Assurance Surveillance Program (QASP) for the facility, operations, stored specimens, shipping materials, and personnel in accordance with all applicable Federal, State, and local regulations. F. Providing a web-based computerized inventory/tracking database for the biospecimens management to support the Aging Research Biobank operations. G. Developing and implementing a transition plan that includes budget to ensure proper documentation of stored biospecimens at the conclusion of the performance period or upon request by the NIA Contracting Officer’s Representative (COR).
Period of Performance
The anticipated period of performance consists of a base year with four 12 month option periods as follows:
Base Period: July 30, 2023 – July 29, 2024
Option Period 1: July 30, 2024 – July 29, 2025
Option Period 2: July 30, 2025 – July 29, 2026
Option Period 3: July 30, 2026 – July 29, 2027
Option Period 4: July 30, 2027 – July 29, 2028
CLOSING STATEMENT
The solicitation will be issued on or about January 6, 2023, and bids or proposals will be tentatively due about 30days after the solicitation release date.
Potential offerors may request a copy of the solicitation from the Contract Specialist, Eric McKay electronically at eric.mckay@nih.gov and must reference the solicitation number HHS-NIH-NIDA-PSOL-75N95022R00091,on your electronic request. FAX requests are not accepted.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity